Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Oct 24;6(1):vdae178. doi: 10.1093/noajnl/vdae178

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2024. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.

PMC Copyright notice

Figure 3. — Waterfall plots of [¹⁸F]FET response metrics. Each bar shows percent change in MTV (A), in TBR_mean (B), and TBR_max (C) of individual patients with [¹⁸F]FET also at follow-up. Dotted lines show PET RANO upper and lower limits for stable disease (SD). Bars are color coded according to MRI RANO response. Subject ID is shown below with font color indicating responder (OS > 11 months) or nonresponder (OS < 11 months, marked with asterisk). Patients #25 and #29 did not fulfill RANO criteria for contrast-enhancing measurable lesions at baseline. PR, partial response; PD, progressive disease; OS, overall survival.